Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome
about
Missing Cells: Pathophysiology, Diagnosis, and Management of (Pan)Cytopenia in ChildhoodThe complex pathophysiology of acquired aplastic anaemiaPredicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score systemAbnormalities of the alphabeta T-cell receptor repertoire in advanced myelodysplastic syndrome.The feature of distribution and clonality of TCR γ/δ subfamilies T cells in patients with B-cell non-Hodgkin lymphoma.STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients.The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromesIFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation.Naive T-cells in myelodysplastic syndrome display intrinsic human telomerase reverse transcriptase (hTERT) deficiency.Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.Immunologic aspects of hypoplastic myelodysplastic syndrome.Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia.Clonotype analysis of cytomegalovirus-specific cytotoxic T lymphocytes.Clonal predominance of CD8(+) T cells in patients with unexplained neutropeniaImmune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome.Effect of IL-7 and IL-15 on T cell phenotype in myelodysplastic syndromes.Immunological derangement in hypocellular myelodysplastic syndromes.Are T-cell dysfunctions the other side of the moon in the pathogenesis of myelodysplastic syndromes?The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes.Myelodysplastic syndromes: toward a risk-adapted treatment approach.A paroxysmal nocturnal haemoglobinuria progress with waldenström macroglobulinemia along with T cell monoclonal expansion.hTERT deficiency in naïve T cells affects lymphocyte homeostasis in myelodysplastic syndrome patientsInterleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.T-cell immunoglobulin mucin-3 is underexpressed on myeloblasts in untreated myelodysplastic syndrome.Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia.Cytomegalovirus-specific regulatory and effector T cells share TCR clonality--possible relation to repetitive CMV infections.Induction of HLA-B*40:02-restricted T cells possessing cytotoxic and suppressive functions against haematopoietic progenitor cells from a patient with severe aplastic anaemia.Monocytes are activated in patients with myelodysplastic syndromes and can contribute to bone marrow failure through CD40–CD40L interactions with T helper cells
P2860
Q26798389-FD3C5A55-D4F7-4D67-9CA3-D9B82003743CQ28082135-C5D643BE-16C7-4A8C-B552-DD4D41E893C3Q33399233-E857FCB3-02DA-42BF-949C-B81F4B97BF7DQ33679140-16BF01B2-EC9A-4C76-B2AF-D814B35F1D48Q33747619-A3061B4C-5EDB-4A5F-B1D8-CD75BB624097Q34362636-53AADC2D-A41B-4FB9-A52C-C74559979214Q34429788-32493B14-E7DD-4914-81C5-65CF8C6752A3Q34683972-F74C8764-B242-4E17-960B-DFEA65D271C6Q35136851-54BA19A8-638D-48D0-AD36-E8F1DF9A76EBQ35193715-95E7FFB0-69D1-4E66-831C-55E8F38B8FE0Q35275808-DEA35B77-5B53-4D3D-A1DF-4A659335F4AEQ37069554-57B307D2-05E4-4CB3-872D-88D5776C6874Q37086635-E89E7BDE-378E-48A3-88DC-43A3BCFAA30DQ37098105-DA12EBFC-19FE-47A9-B42C-DADCD193EAD1Q37146038-F54B24BB-334F-4BA6-847F-1E9F20267D90Q37317299-8575F04A-855D-44B8-9EA0-2DB7285B59D3Q37724605-75F7F471-6A7D-4918-9ED3-0344609C7247Q37980495-5C0031F4-AA60-4C60-8A26-FB6B9708CE4CQ38061848-8053595F-E9DE-4DCC-97D6-598D63B5C836Q38149315-546F99BA-C6EC-4EAD-9D58-FA2CEB744359Q38261657-4B26BBAA-B5F9-4C81-8DD8-C2DDADA7B514Q41788396-09903CBC-255A-42FB-BC9E-FA80A8676B42Q44863267-89C6D892-003D-4891-A9F6-1F46867F966BQ45339828-FC525D15-7553-4FCE-8515-58E4A1550B9AQ50118878-123924EA-B4FC-45FE-9F90-9D8A47BFCBC3Q52891818-C68E4CA3-E97D-4996-8053-A1794CFC6C5DQ52946897-0EA75BA4-8D12-42C4-9B23-383D9F44AEAAQ56777872-DFA014DF-8399-4763-B265-6A1F7ADBC789
P2860
Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndrome
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Molecular strategies for detec ...... a and myelodysplastic syndrome
@ast
Molecular strategies for detec ...... a and myelodysplastic syndrome
@en
type
label
Molecular strategies for detec ...... a and myelodysplastic syndrome
@ast
Molecular strategies for detec ...... a and myelodysplastic syndrome
@en
prefLabel
Molecular strategies for detec ...... a and myelodysplastic syndrome
@ast
Molecular strategies for detec ...... a and myelodysplastic syndrome
@en
P2093
P2860
P1433
P1476
Molecular strategies for detec ...... a and myelodysplastic syndrome
@en
P2093
Eric D Hsi
Jaroslaw P Maciejewski
Lukasz P Gondek
Magdalena Plasilova
Marcin W Wlodarski
Matt Kalaycio
Zachary P Nearman
P2860
P304
P356
10.1182/BLOOD-2005-09-3902
P407
P577
2006-04-13T00:00:00Z